+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 62893-54-3
62893-54-3,MFCD06213695
Catalog No.:AA0035QW

62893-54-3 | 2-Cyclopropylethylamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$120.00   $84.00
- +
1g
98%
in stock  
$236.00   $166.00
- +
5g
98%
in stock  
$926.00   $648.00
- +
10g
98%
in stock  
$1,452.00   $1,017.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0035QW
Chemical Name:
2-Cyclopropylethylamine
CAS Number:
62893-54-3
Molecular Formula:
C5H11N
Molecular Weight:
85.1475
MDL Number:
MFCD06213695
SMILES:
NCCC1CC1
Properties
Properties
 
Storage:
2-8℃;Light sensitive;  

Computed Properties
 
Complexity:
39.2  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
6  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
0.8  

Downstream Synthesis Route

[1]Janusz,JohnM.;Young,PatriciaA.;Ridgeway,JamesM.;Scherz,MichaelW.;Enzweiler,Kevin;Wu,LaurenceI.;Gan,Lixian;Chen,Julian;Kellstein,DavidE.;Green,ShelleyA.;Tulich,JenniferL.;Rosario-Jansen,Theresa;Magrisso,I.Jack;Wehmeyer,KennethR.;Kuhlenbeck,DeborahL.;Eichhold,ThomasH.;Dobson,RoyL.M.[JournalofMedicinalChemistry,1998,vol.41,#18,p.3515-3529]

[2]CurrentPatentAssignee:XENONPHARMACEUTICALSINC-WO2006/34441,2006,A1Locationinpatent:Page/Pagecolumn42

[3]CurrentPatentAssignee:XENONPHARMACEUTICALSINC-WO2006/34338,2006,A1Locationinpatent:Page/Pagecolumn48-49

[4]CurrentPatentAssignee:XENONPHARMACEUTICALSINC-EP2316827,2016,B1Locationinpatent:Paragraph0102

[5]v.Braun;Kuehn;Siddiqui[ChemischeBerichte,1926,vol.59,p.1086]

[6]Kiec-Kononowicz;Wiecek;Sasse;Ligneau;Elz;Ganellin;Schwartz;Stark;Schunack[Pharmazie,2000,vol.55,#5,p.349-355]

[7]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2015/25164,2015,A1Locationinpatent:Page/Pagecolumn59-60

[8]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US2015/57298,2015,A1Locationinpatent:Page/Pagecolumn19

[9]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2008/101867,2008,A1Locationinpatent:Page/Pagecolumn105

[1]Cartier,G.E.;Bunce,S.C.[JournaloftheAmericanChemicalSociety,1963,vol.85,p.932-937]

62893-54-3    178322-41-3   
7-tert-butyl-N-(2-cyclopropylethyl)-2,3-dihydro-3,3-dimethyl-5-benzofurancarboxamide 

[1]Janusz,JohnM.;Young,PatriciaA.;Ridgeway,JamesM.;Scherz,MichaelW.;Enzweiler,Kevin;Wu,LaurenceI.;Gan,Lixian;Chen,Julian;Kellstein,DavidE.;Green,ShelleyA.;Tulich,JenniferL.;Rosario-Jansen,Theresa;Magrisso,I.Jack;Wehmeyer,KennethR.;Kuhlenbeck,DeborahL.;Eichhold,ThomasH.;Dobson,RoyL.M.[JournalofMedicinalChemistry,1998,vol.41,#18,p.3515-3529]

[1]CurrentPatentAssignee:PFIZERINC-US2008/70887,2008,A1Locationinpatent:Page/Pagecolumn10

2-(3-bromo-2-oxopyrrolidin-1-yl)-N-(4-fluorobenzyl)-4-methylthiazole-5-carboxamide 
  62893-54-3   
2-(3-(2-cyclopropylethylamino)-2-oxo-pyrrolidin-1-yl)-N-(4-fluorobenzyl)-4-methylthiazole-5-carboxamide 

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2008/36715,2008,A1Locationinpatent:Page/Pagecolumn65

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 62893-54-3
89381-08-8

89381-08-8

 1003-03-8

1003-03-8

 15520-10-2

15520-10-2

 18925-44-5

18925-44-5

 6240-96-6

6240-96-6

 462-94-2

462-94-2
Building Blocks
More >
Tags:62893-54-3 Molecular Formula|62893-54-3 MDL|62893-54-3 SMILES|62893-54-3 2-Cyclopropylethylamine